Stratus Medical
Magnolia
About Stratus Medical
Stratus® Medical's mission is to improve clinical outcomes for chronic pain patients by advancing RF technology for the treatment of pain. The Nimbus® RF Multitined Expandable Electrode provides the interventional pain medicine physician an easy to use, compatible, efficient, cost saving technology that provides a large volume lesion for reproducible and sustained pain relief*. The Nimbus RF procedure takes about 20 minutes and is completed in a procedure suite in the office, ASC or hospital outpatient department. Patients can be treated while awake with numbing medication or sedated, depending on physician and facility preference. Nimbus has been utilized in over 250,000 patient treatments in the United States, Australia, Brazil, Canada, United Kingdom, and other countries. Nimbus is FDA cleared, CE marked, and has 29 issued patents in 14 countries. Stratus Medical also markets complimentary technology including Vesta®, Nimbus Probe and Nimbus Disposable Probe and has several exciting development projects underway.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $26.3M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2026)
- Website: stratusmedical.com
- Phone: 346-703-0642
Industries & Categories
Health Care
Social Profiles
Canonical: https://fsome.com/organization/stratus-medical-951 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.